[FG] Tschudin Sutter Sarah
Research Group Sarah Tschudin Sutter
Research Focus
Immunology & Infectious Diseases
Area of Research
Hospital acquired infections, with a focus on transmission of multi drug-resistant pathogens, and infection prevention and control interventions.
Approved Research Projects
- Transmission of ESBL-producing Enterobacteriaceae (ClinicalTrials.gov Identifier: NCT03465683)
- Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (ClinicalTrials.gov Identifier: NCT04098133)
- SIMPLIFY the Hand Hygiene Procedure - Three Steps Versus Six Steps for Performing Hand Hygiene (SIMPLIFY Study) (ClinicalTrials.gov Identifier: NCT04187040)
Collaborations
National Collaborations
- ANRESIS, Swiss Centre for Antibiotic Resistance, Bern
- Department of Clinical Bacteriology and Mycology, University Hospital Basel
- Cantonal Laboratory of the City of Basel
- Department of Biosystems and Engineering Sciences at ETH Zurich
- National Center for Infection Prevention (Swissnoso)
- Swiss Society for Infectious Diseases (SSI)
- Swiss Society for Hospital Hygiene (SGSH)
- Swiss Antibiogram Committee (SAC), Swiss Society for Microbiology
- Federal Office of Public Health (FOPH)
International Collaborations
- European Working Group for C. difficile (ESCMID Study Group for C. difficile)
- Guideline Subcommittee European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Ongoing Research Projects
- Transmission of ESBL-producing Enterobacteriaceae (ClinicalTrials.gov Identifier: NCT03465683)
- Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene (ClinicalTrials.gov Identifier: NCT03588221)
- Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (ClinicalTrials.gov Identifier: NCT04098133)
- AntiResist: New approaches to combat antibiotic-resistant bacteria (ClinicalTrials.gov Identifier: NCT05017766)
- Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first recurrence (FENDER) (ClinicalTrials.gov Identifier: NCT05266807)